A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy
PHASE1
CC-90011-AML-002 is a Phase 1/2, open-label, multicenter study to assess th...
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
PHASE1
CC-90011-SCLC-001 is a multicenter, Phase 1b, open-label, dose finding stud...